Your browser doesn't support javascript.
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components.
Jing, Lichen; Wu, Xia; Krist, Maxwell P; Hsiang, Tien-Ying; Campbell, Victoria L; McClurkan, Christopher L; Favors, Sydney M; Hemingway, Lawrence A; Godornes, Charmie; Tong, Denise Q; Selke, Stacy; LeClair, Angela C; Pyo, Chu-Woo; Geraghty, Daniel E; Laing, Kerry J; Wald, Anna; Gale, Michael; Koelle, David M.
  • Jing L; Department of Medicine.
  • Wu X; Department of Medicine.
  • Krist MP; Department of Medicine.
  • Hsiang TY; Department of Immunology, and.
  • Campbell VL; Department of Medicine.
  • McClurkan CL; Department of Medicine.
  • Favors SM; Department of Medicine.
  • Hemingway LA; Department of Medicine.
  • Godornes C; Department of Medicine.
  • Tong DQ; Department of Medicine.
  • Selke S; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • LeClair AC; Department of Medicine.
  • Pyo CW; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Geraghty DE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Laing KJ; Department of Medicine.
  • Wald A; Department of Medicine.
  • Gale M; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Koelle DM; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
JCI Insight ; 7(6)2022 03 22.
Article in English | MEDLINE | ID: covidwho-1673605
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
SARS-CoV-2 provokes a robust T cell response. Peptide-based studies exclude antigen processing and presentation biology, which may influence T cell detection studies. To focus on responses to whole virus and complex antigens, we used intact SARS-CoV-2 and full-length proteins with DCs to activate CD8 and CD4 T cells from convalescent people. T cell receptor (TCR) sequencing showed partial repertoire preservation after expansion. Resultant CD8 T cells recognize SARS-CoV-2-infected respiratory tract cells, and CD4 T cells detect inactivated whole viral antigen. Specificity scans with proteome-covering protein/peptide arrays show that CD8 T cells are oligospecific per subject and that CD4 T cell breadth is higher. Some CD4 T cell lines enriched using SARS-CoV-2 cross-recognize whole seasonal coronavirus (sCoV) antigens, with protein, peptide, and HLA restriction validation. Conversely, recognition of some epitopes is eliminated for SARS-CoV-2 variants, including spike (S) epitopes in the Alpha, Beta, Gamma, and Delta variant lineages.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Prognostic study / Randomized controlled trials Topics: Variants Language: English Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Prognostic study / Randomized controlled trials Topics: Variants Language: English Year: 2022 Document Type: Article